COVID-19 and antiepileptic drugs: an approach to guide practices when nirmatrelvir/ritonavir is co-prescribed
Nadir Yalçın, Karel Allegaert
Topics & Concepts
RitonavirCoronavirus disease 2019 (COVID-19)Medicine2019-20 coronavirus outbreakAntiepileptic drugSevere acute respiratory syndrome coronavirus 2 (SARS-CoV-2)PharmacologyEpilepsyIntensive care medicineVirologyInternal medicineHuman immunodeficiency virus (HIV)Viral loadPsychiatryAntiretroviral therapyOutbreakDiseaseInfectious disease (medical specialty)Pharmacological Effects and Toxicity StudiesEpilepsy research and treatmentDrug Transport and Resistance Mechanisms